BETH BASH: Open Payments
NPI 1225079973 · BUTLER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,444 in 84 payments from 15 companies in 2025. Trend: 2023 $1,219 · 2024 $1,736 · 2025 $1,444
Food & beverage: $1,444
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $219 |
| ABBVIE INC. | 13 | $176 |
| Novo Nordisk Inc | 9 | $175 |
| Amgen Inc. | 11 | $164 |
| PFIZER INC. | 8 | $146 |
| Lilly USA, LLC | 6 | $144 |
| AstraZeneca Pharmaceuticals LP | 6 | $107 |
| Exact Sciences Corporation | 4 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
Products named: TRELEGY ELLIPTA, OTEZLA, MOUNJARO, PAXLOVID, Ozempic, UBRELVY, Cologuard Collection Kit, BREZTRI.
Industry payments across PA — which companies pay providers there.
